‘Donald Trump’s push for lower drug prices to benefit Indian pharma’ Industry-The Economic Times — January 26, 2017 comments off A Glenmark spokesperson said Indian pharma companies are known to offer products at lesser prices and it will look to address the rising drug prices.
A Glenmark spokesperson said Indian pharma companies are known to offer products at lesser prices and it will look to address the rising drug prices.